Retina
-
We assess for frequency and predictive factors related to sustained intraocular pressure (IOP) elevation in eyes with neovascular age-related macular degeneration receiving intravitreal injections of ranibizumab and/or bevacizumab. ⋯ A greater number of intravitreal anti-vascular endothelial growth factor injections is associated with an increased risk for sustained IOP elevation in eyes with neovascular age-related macular degeneration receiving intravitreal ranbizumab and/or bevacizumab.
-
To analyze the viscoelastic properties of the chopped vitreous at different cut rates to better understand complex fluidic behavior of chopped vitreous during vitrectomy. ⋯ Cut rate affects the rheologic properties of the chopped vitreous and, therefore, its flow inside the vitrectomy system. It is essential to account for both viscosity and elasticity of chopped vitreous to understand flow behavior during vitrectomy.
-
To establish the prevalence of anticoagulation (vitamin K antagonists) and antiplatelet agent therapy in patients undergoing vitreoretinal surgery and to compare the outcome of peribulbar anesthesia and vitreoretinal surgery between users and nonusers. ⋯ Peribulbar anesthesia for vitreoretinal surgery can probably be performed safely in patients receiving anticoagulants. However, retinal surgeons should be aware that severe bleeding complications are more frequent in patients receiving antiplatelet therapy.
-
To determine the long-term functional and anatomical outcome of idiopathic uveitic cystoid macular edema (UCME). ⋯ Cystoid macular edema is a major complication in uveitis. Current management provides satisfactory long-term results for the majority of those individuals. Visual acuity 1 month after the intervention is usually indicative of the final functional outcome.